Additionally, survival analysis showed that GNA13 expression could significantly stratify OS in a subset of GC patients with different age, gender, T status, N status, M status, overall clinical stage, tumor grade and tumor size (P < 0.05, Supplementary Figure S3). This evidence concerns the gene GNA13 and neoplasm.